These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23975787)

  • 21. Whole genome methylation profiling by immunoprecipitation of methylated DNA.
    Sharp AJ
    Methods Mol Biol; 2012; 925():69-78. PubMed ID: 22907491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenomic mapping in Arabidopsis using tiling microarrays.
    Martienssen RA; Doerge RW; Colot V
    Chromosome Res; 2005; 13(3):299-308. PubMed ID: 15868423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells.
    Falk J
    IDrugs; 2010 Mar; 13(3):169-74. PubMed ID: 20191433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MeDIP-HMM: genome-wide identification of distinct DNA methylation states from high-density tiling arrays.
    Seifert M; Cortijo S; Colomé-Tatché M; Johannes F; Roudier F; Colot V
    Bioinformatics; 2012 Nov; 28(22):2930-9. PubMed ID: 22989518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic changes in virus-associated human cancers.
    Li HP; Leu YW; Chang YS
    Cell Res; 2005 Apr; 15(4):262-71. PubMed ID: 15857581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of tiling arrays and their application to bacterial transcriptome analysis.
    Akama T; Nakamura K; Tanoue A; Suzuki K
    Methods Mol Biol; 2013; 1067():23-34. PubMed ID: 23975783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
    D'Alessio AC; Szyf M
    Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis.
    Liu BH; Goh CH; Ooi LL; Hui KM
    Oncogene; 2008 Jul; 27(29):4128-36. PubMed ID: 18332864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [DNA methylation profiling in cancer: from single nucleotides towards methylome].
    Moskalev EA; Eprintsev AT; Hoheisel JD
    Mol Biol (Mosk); 2007; 41(5):793-807. PubMed ID: 18240563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HAT: hypergeometric analysis of tiling-arrays with application to promoter-GeneChip data.
    Taskesen E; Beekman R; de Ridder J; Wouters BJ; Peeters JK; Touw IP; Reinders MJ; Delwel R
    BMC Bioinformatics; 2010 May; 11():275. PubMed ID: 20492700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional activation of the cancer genome by long-range epigenetic remodeling.
    Bert SA; Robinson MD; Strbenac D; Statham AL; Song JZ; Hulf T; Sutherland RL; Coolen MW; Stirzaker C; Clark SJ
    Cancer Cell; 2013 Jan; 23(1):9-22. PubMed ID: 23245995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods of DNA methylation analysis.
    Shen L; Waterland RA
    Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):576-81. PubMed ID: 17693740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of DNA strand-specific differential expression with high density tiling microarrays.
    Quintales L; Sánchez M; Antequera F
    BMC Bioinformatics; 2010 Mar; 11():136. PubMed ID: 20233458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of epigenetic transcription repression and DNA methyltransferases in cancer.
    Daniel FI; Cherubini K; Yurgel LS; de Figueiredo MA; Salum FG
    Cancer; 2011 Feb; 117(4):677-87. PubMed ID: 20945317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tiling array].
    Hiromi N
    Tanpakushitsu Kakusan Koso; 2004 Dec; 49(17 Suppl):2684-7. PubMed ID: 15669239
    [No Abstract]   [Full Text] [Related]  

  • 40. MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.
    Yalcin A; Kreutz C; Pfeifer D; Abdelkarim M; Klaus G; Timmer J; Lübbert M; Hackanson B
    Leuk Res; 2013 Jan; 37(1):102-11. PubMed ID: 23062266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.